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ABSTRACT
Michelle K. Baker
THE EXTRACTION OF CYTOCHROME C AND DSRED2 INTO REVERSE
MICELLES
2008/09
Dr. Stephanie Farrell
Master of Science in Chemical Engineering
Cytochrome c and DsRed2 were successfully extracted into reverse micelles by the
contacting of an aqueous protein-containing phase with an organic phase. Two important
properties that differentiate the extraction profiles of these proteins are pI and size.
Cytochrome c is a relatively small, monomeric protein with a pI of 10.6. It was easily
extracted into reverse micelles with the anionic surfactant AOT. DsRed2, however, is a
large tetramer with a p1 of 6.3. It could not be extracted into AOT, but was extracted with
the cationic surfactant CTAB, and with a wider error range than cytochrome c. CD data
indicate the secondary structure of the proteins may change with solubilization into
reverse micelles, despite absorption interference from the micelles. The results of this
thesis suggest that extraction of certain proteins into reverse micelles is a viable primary
separation step for the recombinant biotechnology industry. However, each process will
have to be optimized to the protein of interest, as protein extraction is specific to certain
properties and is extremely sensitive.
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CHAPTER I
Introduction
Background
The solubilization of hydrophilic proteins in reverse micelles (RMs) has great
potential as a primary separation step in the downstream processing of recombinant
biotechnology. In the biotech industry, downstream processing is expensive; it is
responsible for the majority of production costs. Downstream processing is also time-
consuming and complex. The proteins of interest are similar to other components in the
growth media and must retain their biological activity. The process must achieve a high
separation with a large throughput. Therefore, any new technology that reduces the cost,
the amount of energy needed, or the complexity will be extremely beneficial and
important to the process.1-3
Recombinant processes are very specific to the application, to the source of the
biomolecule (mammalian, microbial, etc.) and to the properties of the protein. Proteins
produced from recombinant bacteria will need to be separated from the fermentation
broth. First, the bacterial cells are harvested by centrifugation or by membrane filtration.
The cells may be washed by diafiltration to remove soluble impurities; this can also set
the pH and the salt concentration. In order to break the cell wall and release the proteins,
the cells are subjected to chemical treatments such as ethylenediaminetetraacetic acid
(EDTA) and lysozyme before mechanical disruption. The resulting cell lysate is then
clarified by centrifugation or by membrane filtration. If the protein present is an inclusion
body, it is located in the cell pellet, but if soluble, the supernatant. The inclusion bodies
are washed, denatured, and allowed to refold. After primary recovery and separation, the
protein is then purified, usually by several filtration (ultra, nano, tangential flow) and
chromatography (expanded bed adsorption, ion exchange, hydrophobic interaction, size
exclusion, affinity) steps. A final purification step may include sterile filtration to remove
bacteria or membrane filtration to remove viruses. Proteins recombinantly grown in
mammalian cells are produced extracellularly and the process therefore avoids cell lysis.4
There are several reviews available detailing the current and potential bioseparation
equipment. "g
Liquid-liquid extraction of proteins by reverse micelles can be scaled up to
operate continuously as a primary separation step with readily available liquid extraction
equipment such as mixer-settlers and contactors. 9 In fact, RMs have been shown to lyse
whole bacterial cells, with a back extraction step recovering the protein of interest for
purification, greatly reducing the pre-chromatography steps.1 ° The characteristics of RMs
and the factors and forces influential in protein solubilization are detailed below.
Protein Solubilization in Reverse Micelles
In reverse micelles, the polar head groups of the surfactant are ordered around a
water pool, while the hydrophobic tails of the surfactant interact with the bulk organic
solvent. Figure 1 below depicts a cartoon of protein solubilization in RMs. A variety of
surfactants exist, with the anionic AOT (sodium
diethylhexylsulfosuccinate)/isooctane/water ternary system the most well studied since it
does not require a cosurfactant.
organic solvent
dth surfactant
4ow
1. contacting of phases
2. separation by
centaifuation
Solouilization of protein in
RM, aqueous and organic
aqueous solutionwith tpase in equiihrionm
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Figure 1. Cartoon Representation of Protein Solubilization in RM, adapted from Melo et al."
Micellar collisions allow the water pools to occasionally exchange contents
regardless of the chemical properties of the -contents. The siz  of the micelle depends on
the ratio of the concentration of water to the concentration of surfactant (in moles),
known as WO, provided the surfactant concentration is greater than the critical muicelle
concentration (CMC). The parameter, Wo, is also considered important for protein
selectivity and enzyme activity. At low values of W0, all water molecules in the RM are
bound to the surfactant head groups, causing the micelles to be rather inflexible. As W0
increases (Wo > 10), some water molecules are attached to the surfactant head groups and
some are free in the core of the RM, giving the micelles a dynamic flexibility. Also, as
WO increases, the size of the water pool increases.11
The water pool has different physical and chemical properties than bulk water and
is dependent on the conditions of the micelle. Therefore, it is necessary to experimentally
analyze the conditions required for protein solubilization and characterize the properties
of the micelle. Protein solubilization in RMs is driven by both electrostatic and
hydrophobic interactions. These driving forces are affected by many properties. In the
aqueous phase, the protein concentration, the salt type and concentration, the buffer type
and concentration, and the pH affect the driving forces. In the organic phase, the
surfactant type and concentration, the solvent type and concentration, and the presence of
co-surfactants or co-solvents affect the driving forces. With respect to the micelle, the
size and shape of the micelle (characterized by Wo) affect the driving forces. The size and
shape, isoelectric point (p1), charge distribution, and hydrophobicity of the protein
influence the location of the protein in the RM (water pool, head or tail of surfactant) and
also the driving forces. A variety of biophysical chemistry techniques has been used to
characterize the micelles, such as dynamic light scattering, fluorescence, circular
dichroism (CD), Fdrster resonance energy transfer (FRET), and nuclear magnetic
resonance (NMR).1 2 19 There are several excellent reviews on the important factors in
extracting proteins into reverse micelles.
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Forward Transfer Methods
There are three methods for transferring a protein into a RM. The phase transfer
method, the most applicable to continuous processing in the biotech industry, involves
contacting an aqueous phase containing the protein and an organic phase. The resultant
reverse micelles in the organic phase are in equilibrium with the bulk aqueous phase. The
injection method involves injecting a solution with soluble protein into an organic phase
with empty RMs. The solid-liquid method involves mixing lyophilized protein with an
organic phase containing empty RMs. Hashimoto et al. 25 added solid, denatured
ribonuclease A to empty micelles and allowed the enzyme to refold. The study was
applicable to proteins that are produced as inclusion bodies, which may need to be
separated and refolded.
After solubilization, the protein may be located in the water pool, in contact with
the polar head group, or in contact with the hydrophobic tail. The location depends on the
protein and its properties.
Electrostatic Forces
Electrostatic forces in this context refer to the interactions between the charges on
the polar head of the surfactant and the charges on the protein. They are usually strongest
during forward transfer when a protein is below its p and is extracted into a RM with an
anionic surfactant or when a protein is above its pI and is extracted into a RM with a
cationic surfactant. The presence of salt or buffer can interfere with electrostatic forces,
either by the "salting out" effect or by Debye screening due to a reduction in the Debye
length. Examples of the influence of electrostatic interactions are presented below.
pH
If electrostatic interactions are the main driving force for protein solubilization,
then the pH of the aqueous phase and water pool are important. Wolbert et al.26 studied
the effect of aqueous pH on the solubilization of nineteen proteins into
trioctylmethylammonium chloride (TOMAC)/nonylphenol pentaethoxylate (Rewopal
HV5)/isooctane and AOT/isooctane. With few exceptions, the researchers were able to
extract the proteins that were oppositely charged of the surfactant, confirming the
importance of electrostatic forces for forward transfer. As stated previously, a protein in
an environment with the pH lower than its pl will be able to transfer with an anionic
surfactant, and vice versa. Wolbert et al. determine that the size of the protein is also
important in determining the optimal pH for transfer, as a larger protein needs a larger
driving force, i.e. pi - pH. They also discovered that at higher ionic strengths, a larger
difference is needed for pI - pH.
Salt Concentration
A low salt concentration is needed for the forward transfer of proteins to prevent
emulsions. For extraction that is driven mainly by electrostatic interactions, the salt
concentration becomes an important parameter in solubilization, along with pH. At
higher ionic strengths, the solubilization of a protein decreases as the amount of ions
increases. The presence of ions decreases the electrostatic interactions between the head
group of the surfactant and the protein by Debye screening.
G6klen and Hatton27 solubilized positively-charged cytochrome c into the anionic
AOT/isooctane system rapidly at low ionic strength and then back transferred the protein
at high ionic strength, but more slowly. Forward transfer was relatively fast (order of
seconds) while back transfer was slower (order of minutes). These results indicated to the
researchers that the extraction of cytochrome c is dominated by electrostatic interactions
between the charged protein and the inside of the micelle. Goklen and Hatton suggested
that the type of salt may influence the driving force, as a protein may interact differently
with different salts.
Surfactant: Type and Concentration
The type of surfactant (anionic, cationic, nonionic28, zwitterionic 29) needed is
dependent on the properties of the protein. Some surfactants need a co-surfactant or co-
solvent to form stable reverse micelles. New surfactants are also being designed for better
protein transfer.3° AOT (anionic) and CTAB (cetyl trimethylammonium bromide,
cationic) are the most commonly studied surfactants. Melo et al.31 discovered from
dynamic light scattering that 1-hexanol increased the size of the cutinase-encapsulated
AOT micelle. The change in size of the micelle changed the interfacial characteristics,
which then prevented protein denaturation.
The surfactant concentration required for transfer is related to the concentration of
protein in the aqueous phase. Larger concentrations of protein require larger
concentrations of surfactant. However, too much surfactant can lead to crowding and
difficulty in back transfer. Ichikawa et al.32 investigated the extraction of cytochrome c
into AOT/isooctane with respect to the amount of solubilizing water in the RM. The
researchers determined the minimal AOT concentration in different conditions, defined
as the AOT concentration for 100% extraction. They found that it increased as the
aqueous protein concentration increased and as the ionic strength increased, and was
affected by the pH in the aqueous phase.
Hydrophobic Forces
Hydrophobic forces refer to interactions between the hydrophobic regions on the
protein and the hydrophobic tails of the surfactant. They are usually responsible for back
transfer and are strongly dependent on temperature.
Pires and Cabral33 extracted cytochrome b5 into CTAB/cyclohexane/decanol. By
adjusting the parameters, the researchers were able to extract the protein with either
electrostatic or hydrophobic interactions as the main driving force. Electrostatic forces
extracted the protein at low ionic strength and a pH far from the pl. However,
hydrophobic forces extracted the protein at a pH close to the pl. Hydrophobic forces were
further confirmed for the latter case because the extraction was independent of ionic
strength (above 0.4 M KC1) and the extraction was temperature-dependent. Hydrophobic
forces have more influence at higher temperatures.
Hebbar et al.34 investigated the solubilization of a large protein (66 kDa) into a
nonionic surfactant, polyoxyethylene p-t-octylphenol (Triton-X-100)/toluene, and
AOT/toluene. Bovine serum albumin (BSA) was not extracted into Triton-X-100/toluene
reverse micelles even though the micelle size was larger than the protein. The researchers
concluded there was not enough of a driving force between BSA and the nonionic
surfactant. The protein was extracted into AOT/toluene at a pH higher than the pl,
indicating the extraction was dominated by hydrophobic forces. Adding the protein to a
mixture of Triton-X-100 and AOT in isooctane lowered the extraction efficiency, as the
hydrophobic driving force decreased without a comparable increase in electrostatic
interactions.
Backward Transfer
The traditional method of protein back-extraction from the organic phase to a new
aqueous phase involves increasing the ionic strength and changing the pH to cause
unfavorable electrostatic interactions between the surfactant and the protein and to expel
the protein by size exclusion due to the added salt presence.
Alcohol addition to RMs35 has been known to help back-extraction by controlling
micellar interactions. Other back-extraction techniques involve the use of silica36 or the
addition of a counter-ionic surfactant.37
Realistic Conditions: Mixtures and Broth
Once the requirements for solubilization of small proteins in RMs were
established, this knowledge was applied to crude and artificial mixtures of proteins.
38
'
39
Bansal-Mutalik et al. 40 successfully extracted alkaline phosphatase from the periplasm of
E. coli using several surfactants, after the cell culture had been centrifuged. Jarudilokkul
et al.41 selectively separated 3 proteins (cytochrome c, lysozyme, and ribonuclease A)
from filtered fermentation broth using AOT/isooctane and discovered that low molecular
weight positively charged amino acids and phospholipids in the broth acted as co-
surfactants.
Scale-Up
Small scale-up of reversed micellar protein extraction has been done with a
variety of equipment: membrane reactor,42'43 3-phase fiber reactor,4 4 and high-speed
counter-current chromatography column.45 Stuckey et al.4 6 '4 7 chose a Graesser contactor
for scale-up because the contactor prevented emulsions from forming, a common
problem in reverse micelle scale-up.
Other Biomrnolecules
A brief literature search will also uncover other biomolecules that can be
extracted: nucleic acids, enzymes, bacteria, whole cells, etc. The field of biocatalysis has
added much insight to the extraction of proteins (enzymes) into reverse micelles. If the
activity of an enzyme is not compromised by solubilization into a RM, the reaction can
9
occur in the RM after the addition of substrates. Biocatalysis in RMs is especially
beneficial for enzymes with insoluble substrates.
48,49
Proteins in This Thesis
The proteins used in this thesis are cytochrome c (horse heart) and DsRed2, These
proteins are different in size, secondary and tertiary structure, and pl. The backgrounds of
these two proteins are described below.
Cytochrome c
Cytochromes are hemeproteins that alternate between Fe2+ and Fe 3 oxidation
states during electron transport. Cytochrome c is associated with the inner mitochondrial
membrane, where it is involved in the electron transport chain. It is responsible for the
transfer of electrons from cytochrome c reductase (Complex III) to cytochrome c oxidase
(Complex IV) for the eventual production of adenosine triphosphate (ATP).50 Also, the
protein can disengage from the mitochondrion and activate apoptosis.
The properties of cytochrome c are well known. In fact, it is used as a standard for
electrophoresis and mass spectrometry, among other applications. 52 It is a single
polypeptide chain with several a-helices. 53 Cytochrome c (horse heart) is well
characterized in AOT reverse micelles. It is known to be located at the inner interface of
reverse micelles.54 Some properties of the protein are listed in Table I below.
DsRed2
The green fluorescent protein (GFP) cloned from the jellyfish Aequorea victoria
has revolutionized the study of gene expression and of protein-protein interactions. Most
GFP mutants have absorption wavelengths in the blue, green, or yellow wavelengths.
However, fluorescent proteins with longer wavelengths are desirable for gene expression
10
and FRET. Matz et al., supported by Clontech Laboratories, hypothesized that GFP
homologs might be found in nonbioluminescent organisms. The researchers were
successful in cloning six fluorescent proteins from coral (Anthozoa species). The six
proteins had only a 26-30% primary sequence identity with GFP, but shared a secondary
structure, the f-can. One protein, from Discosoma species, was found to be significant
due its reported red-shifted absorption maxima (558 nm) and emission maxima (583
nm).55 Clontech commercialized the protein under the name DsRed, allowing the
widespread research of its unique properties. DsRed2, with six mutations, has better
solubility, brightness, and expression.s6
Despite its potential, DsRed and its mutants have some disadvantages. The
protein oligomerizes into a tetramer, which is problematic for many biochemical
techniques.57 It has been shown that the oligomerization is essential for the maturation of
DsRed from its immature form to its mature red form.58 Also, the protein has a long
maturation time, 24 hours, according to Clontech.
There are very few research studies on the extraction of DsRed or DsRed2 into
reverse micelles. Verkhusha et al.59 determined the stability of GFP mutants (including
DsRed) by subjecting the proteins to high pressure and AOT reversed micelles. The
fluorescence of DsRed was found to be relatively stable solubilized in reversed micelles
with We from 10 to 30. Connell6 solubilized DsRed2 in CTAB/isooctane/hexanol and
determined the pH, salt, and surfactant extraction profiles. Properties of DsRed2 are
listed in Table 1 below.
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Table 1. Comparison of Proteins
Property DsRed2 Cytochrome c, fromhorse heart
Color hot pink red
Molecular Weight (kDa) 10361 1262
Isoelectric Point (pl) 6.3 10.6
Excitation Maximum 56363 41064
(nm)
Oligomerization tetramer monomer
Secondary Structure f3-can a-helical
Extinction coefficient 43,80063 106,00065
(M-1cm -1)
Far-UV Circular Dichroism
Circular dichroism (CD) is a very useful physical chemistry technique for
studying the folding and binding of proteins and protein interactions. More importantly, it
can help determine the structure of proteins. Near-UV (250-300nm) CD spectra can
indicate characteristics of the tertiary structure. Far-UV (190-250nm) CD spectra can
indicate the secondary structure. Proteins with a-helices have a positive band at 193nm
and negative bands at 208 and 222nm. Proteins with /-strands have a positive band at
195nm and a negative band at 218nm. Extended (disordered) proteins have a negative
band near 195nm and a low ellipticity above 210nm.
66
CD measurements of proteins have been used in many studies to research the
conformational changes between the protein in aqueous solution and in reverse
micelles. 12' 13',16,19 The usefulness of this technique for reverse micellar solutions is limited
by the requirements of CD spectroscopy. For instance, many buffer systems are not
compatible with CD spectroscopy, or must be used at extremely low concentrations.
12
Therefore, not all protein-containing reverse micellar solutions can be studied with
identical conditions in CD. Also, reverse micelles can interfere with absorption in CD
measurements.' 8 Nevertheless, this technique can still provide important information
about the structure of proteins in RMs.
CD measurements of cytochrome c have been studied under many conditions,
including reverse micelles.18 Naoe et al. 17 studied the CD data of cytochrome c (and
lysozyme and ribonuclease A) to determine the influence of the protein and the micellar
interface interactions on the structure of proteins in reverse micelles. The researchers
concluded that the higher order content of cytochrome c in reverse micelles is strongly
affected by micelle water content, micellar curvature, surfactant concentration, and
solvent type due partly to the protein's location at the micellar interface. DsRed and
DsRed2 have been studied with both near and far-UV CD,6 7'73 but not under reverse
micellar conditions. However, other spectroscopy techniques have been used on DsRed
59
or DsRed268 encapsulated in reverse micelles.
13
CHAPTER II
Purpose of Experiment
The aim of this thesis is to determine the extraction profiles of two proteins,
cytochrome c and DsRed2, into reverse micelles. The surfactant concentration, salt
concentration, and pH will be the factors studied to determine the influence of
electrostatic or hydrophobic interactions on protein extraction. The well-studied
surfactants, AOT and CTAB, will be employed. Also, the far-UV circular dichroic (CD)
measurements will be analyzed to determine the secondary structure of the proteins in
reverse micelles.
14
CHAPTER III
Materials and Methods
Cytochrome c
Cytochrome c from equine heart was purchased from Sigma (C2506).
Cytochrome c Surfactant Experiment
The aqueous phase consisted of 0.5g/L cytochrome c, 0.3M N4CI, and 0.02M
Tris, pH -9.7. The organic phase consisted of 5 to 50mM AOT (docusate sodium salt,
Sigma, D4422) in isooctane (2,2,4-trimethylpentane, Sigma, 258776).
Cytocisrome c Salt Experiment
The aqueous phase consisted of 0.5 gIL cytochrome c, 0.02M Tris, pH '-9.7, and 0
to 0.8M NaCi. The organic phase consisted of 50mM AOCT in isooctane.
Cytochrome cepH Experiment
The aqueous phase consisted of 0.5g/L cytochrome c, 0.3M NaCi, 50mM buffer,
and p11 from 4 to 11 (using acetic acid (Fisher, A49 1), sodium acetate (Fisher, BP333),
sodium phosphate dibasic (Fisher, S373), sodium phosphate monobasic (Fisher, S381),
sodium carbonate (Fisher, S495), sodium bicarbonate (Fisher, 8233)). The organic phase
consisted of 50mM AOT in isooctane.
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Cytochrome c Analysis
900uL of both phases were contacted in a 2nL glass vial (Fisher, 03-339-22A)
and were mixed for 1 hour on a rotisserie (Barnstead Labquake, 400110). The vials were
then centrifuged for 20 minutes at 3000g. The top, organic phase was pulled off, placed
in a micro-cell glass cuvette (Fisher, 14-385-914A,I11cm), and the absorbance was
read at 41Onm on a UV.isible spectrophotometer (Hewlett-Packard, 8453). The bottom,
aqueous phase was not read due to surfactant contamination. The blank was isooctane
since empty RMs in isooctane gave negative readings. The glass cuvettes were washed in
a Vakuwash cell washer (Fisher, 14-385-937) with deionized water, isooctane, and
acetone (Fisher, A949) between samples, and nitric acid (Fisher, A200) between runs and
experiments.
Using the absorbance, the concentration of the protein extracted to the organic
phase was determined from Beer's law:
A =
where A is the absorbance at the excitation maxima (unitless), e is the extinction
coefficient in M-'cm"', c is the concentration in M, and / is the pathlength of the glass
cuvette in cm. The extraction yield was determined by
conc of protein in organic phase
%ild =- 100
actual initial conc. of protein in aqueous phase
This equation removes error introduced by the literature values of c.
Cytochrome c Far-LUV CD
The circular dichroic measurements were taken with a Jasco J-8 10 CD
16
(l00mdeg) sensitivity, 260 to 19Onm, Inm pitch, continuous scanning mode, 50 nm/mm
scanning speed, lmsec response, 5nm bandwidth, and 80450 accumulation. The
measurements of a blank aqueous solution (0.2M NaCl, 5mM phosphate buffer) were
subtracted from the measurements of an aqueous solution of cytochrome c (30 M
protein, 0.2M NaCI, 5mM phosphate buffer). The measurements of an empty micelle
organic solution (resulting from 0.2M NaCI, 5mM phosphate buffer contacted with
50mM AOT in isooctane) were subtracted from the measurements of cytochrome c
micelles (resulting from 3OjiM protein, 0.2M NaCi, 5mM phosphate buffer contacted
with 50mM AOT in isooctane). Both sets of data were subjected to the means movement
smoothing algorithm with 5-7 convolution width. The y-axis was converted from mdeg to
molar ellipticity.
JsRed2 Growth and Purification
A frozen stock of E. coli BL21(DE3) cells inoculated with the plasmid pET2ld,
kindly provided by Sabrina Bedard in Joshua Wand's lab at the University of
Pennsylvania, was grown in 10Omb of DifcoTM LB Broth- Lennox (Fisher, DF0402 170)
and lOuL of 100mg/niL ampicillin (Fisher, BP1 760) at 37°C and 120rpm in a VWR
incubating orbital shaker. (The pET2 Id plasmid was previously subcloned from the
Clontech pDsked2 plasmid, which contained an ampicillin resistance gene and an IiPTG-
inducible DsRed2 fusion protein.) After three hours, the l~mL of culture was transferred
to 200mL of broth and 200uL of ampicillin. and allowed to grow overnight. The 200mL
culture was then transferred to 1200mb of broth and 1.2mb of ampicillin such that the
initial absorbance of the culture at 600nm was 0.1. The absorbance of the culture was
monitored until Arne 0.8-1.0. when 7S5uL of culturewas set aside as a frozen stock
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with 250uL of 60% glycerol (Fisher, BP229). Also, the culture was induced with 1.2mL
of 100mg/mL IPTG (isopropyl-beta-Dthiogalactopyranoside, Acros, 302790010). The
culture was then allowed to express for 4-5 days, until it was visibly hot pink. The culture
was then centrifuged at 3000g for 15 minutes in a Forma-Scientific to harvest the cells.
The supernatant was discarded and the cell pellet was resuspended in l5mL of 50mM
Tris (Sigma 252859), 200mM NaCI (Sigma $9888), pW8.0 and then placed in -70°C.
Next, the frozen cells were thawed and placed in a metal beaker. 25mM EDTA
(ethylenediaminetetraacetic acid, Acros, 118432500) was added to the cells and allowed
to stir for a half hour at room temperature. 100ug/mL of 22um-filtered chicken egg white
lysozyme (Sigma, I1(7K0676) was then added to the cells and allowed to stir for an hour
at room temperature. The cells were then subjected to five freeze-thaw cycles between -
70°C and 30°C. The cells were then centrifuged for 3000g for 15 minutes. The
supematant was saved and diluted with 25mM Tris, 20mM NaCl, pH8.5 until suitable
for anion exchange purification.
5 to 25mL of dilute protein were anion exchanged on a Amersham Biosciences
AKTA basic 10, starting at 25mM TIris, 20mM NaCl, pHi-8.5 to 25mM Tris, 300mM
NaCl, pWH-8.5 in 6-7 column volumes. Examples of absorbance graphs for typical anion
exchange chromatography for DsRed2 are in Appendix D.
The peak fractions were combined and centrifuged in an Amicon Ultra-l5k
(Millipore UFC905008) centrifugal filter device for 20 minutes at 3000g. The protein
was then buffer-exchanged with 10mM Tris, pH' 8.5 and centrifuged, repeating 4 times.
The resulting concentrated protein was extracted from the filter and placed at 4°C.
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A typical 1.2L cell culture would require 23 anion exchanges, resulting in 8.4$mL
of - 20g/L of concentrated protein. This would give a total yield of -169g or 140mg/L
culture.
The purification of DsRed2 was monitored by the Agilent Bioanalyzer 2100,
which replicates and quantifies gel electrophoresis for proteins. The Agilent Protein 230
reagent kit (containing protein chips, electrode cleaner, a syringe, spin filters, gel matrix,
dye concentrate, sample buffer, and protein ladder) was used for the sizing range 14.230
kDa. Examples of Bioanalyzer outputs are in Appendix D.
DsRed2 Surfactant Experiment
The aqueous phase consisted of 0.5g/L DsRed2, 0.2M NaCI, 50mM carbonate
buffer, pH-9. The organic phase consisted of 25 to 200mM cetyltrimethylammonium
bromide (CTAB, Sigma, 19151) in 90% isooctane/10% hexanol (by volume) with ISOUL
H 20/l10mL organic phase.
DsRed2 Salt Experiment
The aqueous phase consisted of 0.5g/L DsRed2, 50mM carbonate buffer, pH-~9, 0
to 0.75M Na 1. The organic phase consisted of 100mM CTAB in 90% isooctane/ 10°%
hexanol (by volume) with IS0uL H120/l1Om1L organic phase.
DsRed2 pH Experiment
The aqueous phase consisted of 0.5g/L DsRed2, 0.I M NaCl, 50mM buffer, and
pJ1H6-l0.5. The organic phase consisted of 100mM CTAB in 90% isooctane/ 10%
hexanol (by volume) with iS0uL H20/!l0mL organic phase.
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DsRed2 Analysis
The analysis was the same as for cytochrome c, except that the absorbance was
read at 563 nm. The blank for the AOT micelles was isooctane and the blank for the
CTAB micelles was 90% isooctane/10% hexanol.
Statistical Analysis
Each RM experiment was performed three times (runs), with the same starting
solutions. The results were analyzed by UV-visible spectroscopy only once. For
statistical analysis, the results of the three runs for an experiment were averaged and the
standard deviation was found by using the stdev0 function in Excel Office. The averages
were then graphed and the standard deviation was used for both the positive and negative
error bars on the graph.
Far-UV CD
The circular dichroic measurements were taken with a Jasco J-810 CD
spectropolarimeter in a 0. Icm round glass cuvette. The settings were as follows: high
sensitivity, 260 to 190nm, hnm pitch, continuous scanning mode, 50 nm/min scanning
speed, 16msec response, 5nm bandwidth, and 80-150 accumulation. The measurements
of a blank aqueous solution (0.2M NaCI, 1mM phosphate buffer) were subtracted from
the measurements of an aqueous solution of DsRed2 (15 tM protein, 0.2M NaCi, 1mM
phosphate buffer). The measurements of an empty micelle organic solution (resulting
from 0.2M NaC1, 1mM phosphate buffer contacted with 100mM CTAB in 90%
isooctane/10% hexanol) were subtracted from the measurements of DsRed2 micelles
(resulting from 15.M protein, 0.2M NaC1, 1mM phosphate buffer contacted with 100mM
CTAB in 90% isooctane/10% hexanol). Both sets of data were subjected to the means
20
movement smoothing algorithm with 5-7 convolution width. The y-axis was converted
from mdeg to molecular ellipticity.
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CHAPTER IV
Results
Only the most recent, successful experiments are described here. Several
examples of earlier, less successful experiments are presented in Appendix C, as well as a
second method of analysis using the Agilent Bioanalyzer 2100. No conclusions will be
drawn from these data. All raw data for the described experiments below are presented in
Appendix A.
Cytochrome c with AOT
Cytochrome c- Surfactant Experiment
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Figure 2. Cytoebronie c Extraction Yield vs. AOT concentration
(aqueous: .5g/L cyt c, 0.3M NaCI, 0.02M Tris buffer, pH-9.7, organic: 5 to 50mM AOT in isooctane)
Cytoclirome c is easily extracted into reverse micelles at low concentrations of
surfactant. As shown in Figure 2, greater than 90% of cytochrome c was transferred
above 5mM AOT.
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Cytochrome c-Salt Experiment
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Figure 3. Cytochrome c Extraction Yield vs. Salt concentration
(aqueous: 0.5g/L cyt c, 0.02M Tris buffer, pH-9.7, 0 to 0.8M NaCi, organic: 50mM AOT in isooctane)
As expected, cytochrome c was not transferred without salt. Low concentrations
(0.1-0.3M) are needed for greater than 90% yield, with 0.2M having the highest yield.
Higher than 0.3M, the extraction yield decreases dramatically.
Cytochromie c pHExperiment
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Figure 4. Cytochrome c Extraction Yield vs. pH
(aqueous: 0.5g/L cyt c, 0.3M NaCI, 50mM buffer, pHT 4-11, organic: 50mM AOT in isooctane)
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Cytochrome c was over 90% extracted in the pH range 7-8. The protein was
extracted over 80% in the pH range 6-9, but decreased outside of this range.
DsRed2 with AOT
DsRed2 did not transfer with AOT from pH 4.5-11 with surfactant concentrations
50, 200, and 500 mM.
DsRed2 with CTAB
DsRed2 Surfatctant Experiment
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Figure 5. DsRed2 Extraction Yield vs. CTAB concentration
(aqueous: .5gJL DsRed2, 0.2M NaCI, 50mM carbonate buffer, pH-9, organic: 25 to 200mM CTA$3 in
90% isooctane/10% hexanol)
Over 80% of DsRed2 was extracted with surfactant concentrations up to 125mM
CTAB, with the highest extraction yield occurring at 75mM.
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DsRed2 Salt Experiment
NaCI concentration vM)
Figure 6. DsRed2 Extraction Yield vs. Salt concentration
(aqueous: 0.5g/L DsRed2, 50mM carbonate buffer, pWH~9, 0 to 0.75M NaC1, organic: 100mM CTAB in
90% isooctane/10% hexanol)
Over 80% of DsRed2 was extracted with salt concentrations of 0.1M and 0.2M.
The extraction yield decreased greater than 0.2M NaC1. The micelles were not stable at
OM NaCI; the organic phases were cloudy, causing absorbances higher than 100%.
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Figure 7. DsRed2 Extraction Yield vs. pH
Vertical lines: p1 of tsRed2 = 6.3, pKa of CTAB surfactant=9.81 69
(aqueous: 0.5g/ DsRed2, 0.MNaCi, 50mM buffer, pHs 5.9-10.4, organic: 100mM CTAB in 90%
isooctane/l 10% hexanol)
In general, the extraction yield increased with increasing pH. Above 80% of the
protein was extracted from p1H 8.5 -- 9.9. The highest extraction occurred at pH 9.9,
although this point has a large amount of error.
Far-UV CD
Figure 8 below shows fareLJ CD data of aqueous cytochrome c. The data show a
typical CD spectrum for an a--helical protein. It has a positive band at 197nmn and
negative bands at 210 and 222nm.
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CD spectra or aqueous cytocbrome c
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Figure 8. Aqueous cytochrome c far-UV CD
(aqueous: 28.2 jM (0.37g/L) cyt c, 0.2M NaCi, 5mM phosphate buffer)
Figure 9 below shows far-UV CD data of cytoclirome c in reverse micelles. The
spectrum.r still has characteristics of a-helices, but is drastically different from Figure 8,
indicating changes in the secondary structure upon solubilization in RMs.
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Figure 9. Reverse rmicellar cytochrome c far-UV CD
(aqueous: 28.2 ,M (0.37 8/L) cyt c, 0.2M NaCI, 5mM phosphate buffer, organic: 50mM AOT in isooctane,
resulting RM has 16.7pM (0.218g/L) cyt c)
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CD spectra of cytoehrome c micelle
The CD spectra in Figures 8 and 9 were analyzed by CDPro software70 using
three methods of analysis: SELCON3, CONTNLL, and CDSSTR. The individual results
from this software and the average are in Table 2 below where H is helical, S is strand,
Tm is turn, UnRd is unordered, r is regular, and d is distorted. The raw data is in
Appendix B.
Table 2. Analysis of Cytochroie c CD Data
Structure H(r) H(d) S(r) S(d) Tm UnRd Sum
SELCON3 0.113 0.138 0.146 0.077 0.218 0.325 1.017
CDSSTR 0.103 0.141 0.158 0.085 0.254 0.264 1.005
Aqueous CONTINLL 0.113 0.128 0.138 0.075 0.218 0.328 1.000
cyt c 0.110 0.136 0.147 0.079 0.230
0.3064
Average ± ± ± ± 1,008
0.036
0.006 0.007 0.010 0.005 0.021
SELCON3 0.163 0.203 0.028 0.045 0.222 0.3 12 0.973
CDSSTR 0.231 0.226 0.093 0.061 0.150 0.240 1.001
RM CONTINLL 0.130 0.185 0.097 0.045 0.233 0.310 1.000
cyt c 0.175 0.205 0.073 0.050 0.202
0.287 ±
Average ± ± ± ± 004 0.992
0.052 0.02 1 0.039 0.009 0.045
Figure 10 below shows far-UV CD data of aqueous DsRed2. The data show a
typical CD spectrum for a fl-strand protein: there is a positive band at 201lm and a
negative band at 222m.
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CD) spectra of aqueous DsRed2
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Figure 10. Aqueous DsRed2 far-IN CD
(aqueous: 153 M (1.6g/L) DsRed2, 0.2M NaCI, 1 mM phosphate buffer)
Figure 11 below shows far -UV CD) data of reverse micellar DsRed2. The graph
still has characteristics of fl-strands, but is drastically different from Figure 10, indicating
changes in the secondary stmucture upon solubilization in RMs.
CD spectra of tDsRed2 muicelle
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Figure 11. Reverse micellar DsRed2 far-lil CD
(aqueous: 15.3 tM (1 .6gIL) DsRed2, 0.2M NaCI, 1mM phosphate buffer, organic: 100mM OTAB in 90%
isooctane/10% hexanol, resulting RM has 8,4 M (0.87gIL) DsRed2
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The CD spectra in Figures 10 and 11 were also analyzed by CDPro software using
three methods of analysis: SELCON3, CONTINLL, and CDSSTR. The individual results
from this software and the average are in Table 3 with the same abbreviations as Table 2.
The raw data is in Appendix B.
Table 3. Analysis of DsRed2 CD Data
Structure H(r) H(d) S(r) S(d) Tm UnRd Sum
SELCON3 0.049 0.057 0.230 0.122 0.231 0.342 1.031
CDSSTR 0.006 0.036 0.282 0.123 0.249 0.303 0.999
Aqueous - - -___
CONTJNLL 0.026 0.017 0.221 0.098 0.292 0.346 1.000
DsRed2 0.027± 0.037± 0.244 ± 0.114 ± 0.257 ± 0.330±
Average 1.0 10
0.022 0.020 0.033 0.014 0.031 0.024
SELCON3 0.041 0.028 0.262 0.138 0.191 0.368 1.028
C DSSTR .002 0.026 0.281 0.130 0.246 0.304 0.985
kM CONTINLL 0.007 0.053 0.286 0.140 0.221 0.294 1.001
DsRed2
0.015± 0.036± 0.276± 0.136± 0.219± 0.322±
Aeae 0.023 0.015 0.013 0.005 0.028 0.040 105
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CHAPTER V
Discussion
Cytochrome c
The results here will be compared to 4 studies on cytochrome c extraction with
AOT reverse micelles: Connell60, Gokden et al.27, Ichikawa et al.3 , and Jarudilokkul et
al.41
The surfactant experiment supports the trend in previous studies that the
extraction yield of cytochrome c increases as the surfactant concentration increases. An
increase in surfactant concentration increases the driving force. Ichikawa et al. reported
that the minimum AOT concentration for 100% extraction of cytochrome c was 10mM
for 0.5g/L protein and 15mM for igL with pH 7.2-8.2 and 0.1M KCI. Connell reported
that the minimum AOT concentration for over 70% extraction was 20mM at lglL and
10mM for 0.22g/L at pH 9.7 and 0.1IM Nat'. For both studies, the lower protein
concentration required less surfactant for extraction, as expected. However, the large
standard deviations in Connell's study hint that 0.1IM ionic concentration may not be
enough for micelle stabilization.
Jarudilokkul et al. reported that the minimum AOT concentration for over 90%
extraction was 16mM at pH 10, which is a higher concentration than reported here. This
can be explained by the aqueous conditions of both studies. Jarudilokkul et al. had double
the protein concentration (l g/L cyt c) and lower ionic concentration (80% 0.1IM NaCi and
20% 0. IM buffer for total Na~ of 0.1M). Since this study had 0.5g/L cyt c, a lower
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concentration of AOT is needed, leading to a minimum AOT concentration (for over 90%
extraction) at 5mM at pH 9.7.
The salt experiment supports the trend in previous studies that at low ionic
strengths, cytochrome c is extracted, but at high ionic strengths, the extraction yield of
the protein decreases substantially due to a disruption of electrostatic interactions. Giklen
et al. transferred 1 g/L cytochrome c with 0.1M KCI and back-transferred with a fresh
aqueous phase of 1.OM KC1. Ichikawa et al. saw a substantial decrease in extraction yield
in transferring lg/L cytochrome c with greater than 0.2M NaC1. Connell reported a
greater than 90% extraction yield for 0.25g/L cytochrome c (0.02M Tris, pH 9.7) with
0.24M NaCl and greater than 80% extraction for 0.16- 0.40M NaCI. This study agrees
well with Connell's study because for this study, the highest extraction yield was at 0.2M
NaCI and there was greater than 80% extraction for 0.1- 0.4M NaC1.
The pH experiment supports the literature that very little protein is extracted
greater than pH 10, as the p1 of cytochrome c is 10.6. Greater than 10.6, cytochrome c is
negatively charged and will not transfer with an anionic surfactant. The polar head group
of the surfactant (sulfonic acid) has a pKa less than 0.771, and was negatively charged for
the ranges of pH used in the experiment. Jarudilokkul et al. reported that the optimum pH
for extracting 1g/L of cytochrome c is 10 and that greater than 90% of the protein
transferred in the pH range 5 to 11. Ichikawa et al. reported that extraction of 1 g/L
cytochrome c decreased at pHs higher than 10 and that 90% of the protein transferred in
the pH range 6 to 10. Connell reported that 80% of 0.2g/L cytochrome c transferred at pH
7.8. This thesis reports that greater than 80% of 0.5g/L of cytochrome c is transferred in
the pH range 6 -9 and that 90% transferred in the range 7- 9, which is a slightly lower
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profile than previous studies. This could be because this study uses a higher salt
concentration than the other studies, causing a narrower pH profile.
DsRed2
DsRed2 did not extract with the anionic surfactant AOT. For the protein to be
extracted by electrostatic interactions, DsRed2 must be in a pH environment much less
than its pl, 6.3. However, the protein loses its fluorescence and is not stable below pH
4.5.72 ,73 This narrow pH window (4.5-6.3) does not allow for strong enough electrostatic
interactions to extract DsRed2 into an AOT micelle. For the protein to be extracted above
its pl, there must be a strong hydrophobic driving force, which did not occur. Therefore,
DsRed2 could not be extracted by electrostatic or hydrophobic interactions into the
AOT/isooctane system in this thesis. A previous study59 was able to extract DsRed from a
dilute aqueous solution (0.05mg/ml protein, 50mM Tris-HCI buffer, pH 8) into an AOT
micelle by the injection method. The success of this study in extracting DsRed may be
due to the difference between DsRed and DsRed2, or between the injection and phase-
transfer methods.
For DsRed2 extraction with CTAB, the results here will be compared to one
similar study (Connell60). For DsRed2 extraction with varying surfactant concentration,
Connell reported no minimum surfactant concentration, as all DsRed2 was over 90%
extracted from 5-100mM CTAB in 90% isooctane/10% hexanol. Connell's aqueous
phase for the surfactant experiments consisted of 2.4g/L protein, 50mM carbonate buffer,
pH ~9, and no salt. The results here compare well with Connrmell. Over 80% of DsRed2
was extracted with surfactant concentrations up to 125mM. Higher than 125mM, the
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extraction yield decreased slightly to within 70-80% yield, perhaps due to size exclusion
effects.
For DsRed2 extraction varying salt concentration, Connell reported over 80%
extraction below 0.2M NaC1. The extraction yield dropped to 40% at 0.25M, and
decreased rapidly at higher salt concentrations. The results here compare well with
Connell, despite the instability of the micelles with no salt. Over 80% extraction was
achieved with salt concentrations of 0.2M and below. The extraction yield dropped
dramatically with higher salt concentrations. The results of Connell's study and this
thesis indicate that 0.2M NaCl is the maximum salt concentration for DsRed2 extraction
into a reverse micelle.
For DsRed2 extraction varying pH, Connell reported greater than 80% extraction
in the pH range 7-10.5, with pH 9 having the highest yield. This study reports a narrower
extraction profile in that over 80% of DsRed2 was extracted in the pH range 8.5-9.9. This
result can be explained by the salt concentration. Connell did not use salt in the aqueous
phase of the pH experiment, while 0.1M NaCl was used here. The presence of salt
screened the electrostatic interactions between the negatively-charged DsRed2 (above pH
6.3) and the cationic surfactant, leading to a narrower pH profile here. Also, the pKa of
the head group of the surfactant (trimethylamine) is 9.81, which influenced the extraction
yield of the protein at pHs close to and greater than the pKa. The large standard error at
pH 9.9 can be explained by the proximity to the pKa of the surfactant. Greater than the
pKa, the surfactant will be negatively charged and the electrostatic interactions between
the charged head group and the protein will be reduced.
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Further Analysis
As stated earlier, the type and concentration of buffer can affect the solubilization
of proteins into reverse micelles. Data were pulled from the 3 extraction profiles
(surfactant, salt, pH) and CD to analyze the effects of the buffer on extraction yield for
both cytochrome c and DsRed2.
Figure 12 below shows the effect of buffer type and concentration on extraction
yield for cytochrome c. Table 4 summarizes the pulled data in Figure 12. The two points
with the lowest extraction yields have, interestingly, the lowest and highest buffer
concentrations. The point at 5mM buffer may have a low yield because the salt
concentration was too low, despite having a favorable pH, protein concentration, and
buffer concentration. The point at 50mM buffer with the lower extraction yield may have
a low yield because the buffer concentration is too high or the pH is slightly unfavorable.
Therefore, no direct conclusions can be drawn from the graph since each point has
dissimilar conditions (salt, pH, protein concentration, etc.). However, it would be
advantageous to conduct an experiment altering only the concentration and type of buffer
to determine the direct influence on the extraction yield.
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IHuffer Type vs. Extraction Yield for Cytochronw c
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Figure 12. Effect of Bluffer Type on Extraction Yield for Cytoch romne c
Table 4. Pulled Data for Effect of Buffer Type on Extraction Yield for Cytochrome C
Buffer Buffer Salt Protein Extraction StandardExperiment Concentration Concentration p. Concentration Y
Type (mM) (M) (gIL) Yed/ eito
CD Phosphate 5 0.2 8.5 0.37 59.15 n/a
Surfactant
& Salt, Tris 20 0.3 9.7 0.50 102.27 9.20
AveragedPHi Phosphate 50 0.3 8.2 0.5 102.04 2.53
pH Carbonate 50 0.3 9.5 0.5 57.94 6.6
Figure 13 shows the effect of buffer type and concentration on extraction yield for
DsRed2. Table 5 summarizes the pulled data in Figure 13. As with Figure 12, no
conclusions can be drawn from Figure 13 without further investigation.
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Buffer Type vs. Extraction Yield for LsRed2
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Figure 13. Effect of Buffer Type on Extraction Yield for DsRed2
Table 5. Pulled Data for Effect of Buffer Type on Extraction Yield for DsRed2
Buffer Salt Protein Extraction Standard
Experiment Concentration Concentration pH Concentration
Tye (mM) (M)(g) Yil% Deato
CD Phosphate 1 0.2 7.6 1.6 54.89 n/a
Surfactant
& Salt, Carbonate 50 0.2 9 0.5 84.34 9.72
Averaged
pH Phosphate 50 0.1 7.41 0.5 62.62 12.38
pH Carbonate 50 0.1 9.15 0.5 90.83 14.23
Far-UV CD)
The CD spectra of the micellar solutions of both cytocbrome c and DsRed2 are
very different from the aqueous CD spectra, but still retain characteristics of their
respective secondary structure (a-helical or fl-strand). This difference may be due to a
change in the secondary structure of the proteins after solubilization or interference from
the micelle structure, which has been noted in previous studies."8 It would be informative
to perform CT) studies on the aqueousphase after back-transfer, to determine ifany
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Analysis of the data by CDPro software indicates that cytochrome c increases in
helical content upon solubilization. Since the protein is known to solubilize at the interior
interface of RMs, the protein's interactions with the polar head groups of the surfactant
and the enclosed space of the water pool may force the protein into a tighter structure.
Also, the increase in helical content determined by the software can be explained by the
addition of two structures: an a-helical and an extended/denatured protein, which would
result in a graph similar to Figure 9. It has previously been shown that cytochrome c
denatures in AOT reverse micelles, 17' 74' 75 so this is most likely the case here. If the Wo
had been determined for the RMs in Figure 9, the far-UV CD results could be directly
compared to those of Naoe et al.17
For DsRed2, analysis of the data by CDPro software indicates that DsRed2
decreases the content of regular helical, turns, and unordered, but increases the content of
strands (both regular and distorted). The distorted helical content remains the same.
However, the accuracy of the analysis is to be taken into consideration, as the standard
deviations are quite high, especially for helical content. Also, CDSSTR reported a
negative content for regular helical, which is impossible. However, it can be stated that
the CD data indicate some denaturing of DsRed2 in reverse micelles.
The denaturing of these proteins in reverse micelles may be reduced or prevented
by altering the charged surfactant in order to decrease the electrostatic interactions
between the polar head group of the surfactant and the charges on the protein. Wand et
al.76'77 reported using a short AOT analogue and binary and tertiary mixtures of anionic,
cationic, and nonionic surfactants to maintain the structural fidelity of cytochrome c and
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other proteins in reverse micelles. Doussin et al.78 reported synthesizing a zwitterionic
surfactant that increases the amount of time cytochrome c remains stable in RMs.
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CHAPTER VI
Conclusion
Cytochrome c and DsRed2 were successfully extracted into reverse micelles by
the contacting of an aqueous protein-containing phase with an organic phase. Two
important properties that differentiate the extraction profiles of these proteins are pI and
size. Cytochrome c is a relatively small, monomeric protein with a pI of 10.6. It was
easily extracted into reverse micelles with the anionic surfactant AOT. DsRed2, however,
is a large tetramer with a pI of 6.3. The protein could not be extracted into AOT, but was
extracted with CTAB, and with a wider error range than cytochrome c. CD data indicate
the secondary structure of the proteins may change with solubilization into reverse
micelles, despite absorption interference from the micelles.
The results of this thesis suggest that extraction of certain proteins into reverse
micelles is a viable primary separation step for the recombinant biotechnology industry.
However, each process will have to be optimized to the protein of interest, as protein
extraction is specific to certain properties and is extremely sensitive. G6klen and Hatton27
noticed a shift in their data with a change in supply of either protein or surfactant. More
scale-up research is needed before the technique can be successfully adapted in industry.
By then, affinity surfactants will hopefully improve the extraction even further.79 81 Also,
natural surfactants such as lecithin will need to be studied for use in the food and
pharmaceutical industries. 82
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APPENDIX 13
CDPro Data
CDPro Data for aqueous cytoclirome c
SAMPLE: ; cytochrome c aqueous phase
PROGRAM: : SELCON3
Ref. Prot. Set: SM1P56
Structure : H(r) H(d) S(r) S(d) Tm Unrd
Fractions : .113 .138 .146 .077 .218 .325
RMSD(Exp-Calc): .771NRMSD(Exp-Cal) : 364
SAMPLE: :cytochrome c aqueous phase
PROGRAM: : CD)SSTR
Ref. Prot. Set: SMP56
Structure : H1(r) 1(d) S(r) S(d) Tmn tUnrd
Fractions : .103 .141 .158 .085 .254 .264
RMSD(Exp-Calc): .198
NRMSD(Exp-Cal): .093
SAMPLE: : cytochrome c aqueous phase
PROGRAM: : CONTINLL
Ref. Prot. Set: SMP56
Structure : 11(r) H(d) S(r) S(d) Turn Unrd
Fractions : .113 .128 .138 .075 .218 .328
RMSD(Exp-Calc): .123
NRMSD(Exp-Cal): .058
59
CDPro Data for reverse micellar cytochrome c
SAMPLE: : cyt c micelle
PROGRAM: :SELCON3
Ref. Prot. Set: SMP56
Structure 11H(r) H(d) S(r) S(d) Tm Unrd
Fractions: .163 .203 .028 .045 .222 .312
RMSD(Exp-Calc): 1.664
NRMSD(Exp-Cal): .571
SAMPLE: :cyt c micelle
PROGRAM: : CDSSTR
Ref. Prot. Set: 5MP56
Structure : H1(r) 1(d) S(r) S(d) Tmn Unrd
Fractions . .231 .226 .093 .061 .150 .240
RMSD(Exp-Calc): .295
NRMSD(Exp-Cal): .101
SAMPLE: : cyt c micelle
PROGRAM: : CONTINLL
Ref. Prot. Set: 5MP56
Structure : 11(r) 11(d) S(r) S(d) Turn Unrd
Fractions : .130 .185 .097 .045 .233 .310
RMSD(Exp-Calc): .291
NRMSD (Exp-Cal) : .100
-1- .- 0 - - -
CDPro Data for aqueous DsRed2
SAMPLE:: dsred2 aqueous
PROGRAM: : CONTINLL
Ref. Prot. Set: SMP56
Structure : 11(r) H(d) 5(r) S(d) Turn Unrd
Fractions : .026 .017 .221 .098 .292 .346
RMSD(Exp..Calc): .083
NRMSD(Exp-Cal)l: .066
SAMPLE: :dsred2 aqueous
PROGRAM: : CDSSTR
Ref. Prot. Set: SMP56
Structure : 1(r) 1(d) S(r) S(d) Tm Unrd
Fractions : .006 .036 .282 .123 , 249 .303
RMSD(Exp-Calc): .137
NRMSD(Exp-Cal): .110
SAMPLE: : dsred2 aqueous
PROGRAM: : SELCON3
Ref. Prot. Set: SMIP56
Structure : H(r) 11(d) S(r) S(d) Tm Unrd
Fractions : .049 .057 .230 .122 .231 .342
RMSD(Exp-Calc): .533
NRMSD(Exp-Cal): .425
CDPro Data for reverse inicellar DsRed2
SAMPLE:: dsred2 micelle
PROGRAM: : CONTINLL
Ref, Prot. Set: SMP56
Structure : H(r) H(d) S(r) 5(d) Turn Unrd
Fractions: .007 .053 .286 .140 .221 .294
RMSD(Exp-Calc): .079
NRMSD(Exp-Cal): .137
SAMPLE: : dsred2 micelle
PROGRAM: : SELCON3
Rif. Prot. Set: SMIP56
Structure : H(r) H(d) S(r) S(d) Tm Unrd
Fractions : .041 .028 .262 .138 .191 .368
RMSD(Exp-Calc): .435
NRMSD(Exp-Cal): .753
SAMPLE: :dsred2 micelle
PROGRAM: : CDSSTR
Ref. Prot. Set; SMP56
Structure : 1(r) 1(d) S(r) S(d) Tm Unrd
Fractions : -.002 .026 .281 .130 .246 .304
RMSD)(Exp-Calc): .160
NkMSD(Exp-Cal): .277
APPENDIX C
Previous Experiments
One previous experiment for cytochrome c varying surfactant concentrations will
be described here. This experiment was not discussed in the Results section of the thesis
as no conclusions were drawn from the data. There are many more previous experiments
that will not be described here because the data are also unusable and no conclusions
were drawn from them also.
For the experiment below, the absorbances of both the organic and aqueous
phases were measured on a UV-visible spectropolarimeter. It was determined that the
aqueous phases had surfactant contamination, and therefore all experiments in the Results
section analyzed only the organic phases.
A second method of analysis, electrophoresis by Agilent Bioanalyzer 2100, was
used for the experiment below for comparison with the absorbance data. This second
method of analysis was not comparable to the spectropolarimeter; later experiments only
used a UV-visible spectropolarimeter to analyze data.
Cytochrome c Surfactant Experiment- Absorbance Data
Figures 14 and 15 below show the extraction profiles for cytochrome c varying
surfactant concentration using absorbance data from the organic and aqueous phases,
respectively. Tables 12 and 13 summarize the data. The aqueous phases had
contamination from the surfactant, causing higher absorbances. Also, the aqueous and
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organic phases do not equal -100% because of the contamination. Therefore, only the
organic phases of the experiments in the Results section were analyzed.
Cytochrome c- Surfactant, Organic Phase, Absorbance Data
300.00
- 250.00
~ 200.00
FE
pr 10.00
0 10 20 30 40 50 60
AO's Concentration (VIM)
Figure 14, Previous Cytochrome c Extraction Yield vs. AOT concentration
(aqueous : l g/L cyt c, 0.02M 'Trs buffer, pH 9.7, organic: 5 to 50mM AOT in isooctane)
a+
0
Cytochrome c. Surfactant, Aqueous Phase, Absorbance Data
250.00
200.00
150.00
100.00
50.00
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Figure 15. Previous Cytoch rome c Extraction Yield vs. AOT concentration
(aqueous: Ilg/L cyt c, 0.02M Tris buffer, pH-9.7, organic: 5 to 50mM AOT in isooctane)
A Cn.OTI Run #1 Rn1 n3 Average Conc. oc Ag
Al/C.~1~d% AlC ~1d% 4/O ~dd Al/ (M (gI) Yevd
0.7 na
0.445 78.08
0.414 72.59
0.573 100.52
0.531 93.14
0.521 91.31
0.541 94.83
0.541 94.84
0.565 99.01
0.578 101.43
1.621 284.18
0.556 n/a
0.129 23.14
0.227 40.9
0. 361 65.03
0.322 58.01
0.412 74.25
0.413 74.32
0.495 89.11
0.454 81.66
0.436 78.47
0.455 81.86
0.553 n/a
0.417 75.34
0.341 61.67
0.395 71.39
0.385 69.49
0.587 106.13
0.51 92.19
0.613 110.79
0.507 91.53
0.772 139.58
0.552 99.8
0.6 5.28E-06 0.065 na n/a
0.33 3.12E-06 0.039 59 30.96
0.327 3.09E-06 0.038 58.51 16.09
0.443 4.18E-06 0.052 79.18 18.92
0.413 3.89E-06 0.048 73.73 17 .91
0.507 4.78E-06 0.059 90.55 15.95
0.488 4.60E-06 0.057 87.18 11.16
0.55 5.19E-06 0.064 98.2 11.23
0.508 4.80E-06 0.059 90.81 8.7
0.596 5.62E-06 0.07 106.4 30.87
0.876 8.26E-06 0.102 156.48 111.99
intal
5
10
15
20
25
30
35
40
45
50
0
a
C"3
IQ
CD
h
A410 1eld% A40IC e % A410 Held % JA410 (ML) Meld %
0.57 Wa
0.704 123.53
0.525 92.02
0.534 93.58
0.719 126.04
0.54 94.66
0.418 73.25
0.351 61.46
0,222 38.87
0.337 59.12
1.159 203.27
0.556 a
0 .622 111.93
0.46 8.73
0.312 56.2
0.313 56.39
0.275 49.49
0.227 40.88
0.235 42.32
0.496 89.24
0.205 36.95
0.133 23.87
0.553 Wa
0.531 95.99
0,44 5 8.4
0.657 118.7
0397 71.71
0.642 116
0.259 46.8
0.285 51.56
0.309 55.86
0.69 124.71
0,723 130.56
0.56 5.28E-06 0.065 W a
0.619 5.84FE-06 0.072 110.62
0.478 4.51E-06 0.056 85.43 
0.501 4.73E-06 0.059 89.52
0.476 4.49E-06 0.056 85.09
0.486 4.58E-06 0.057 86.75
031 2.84E4J6 005 53.82
0.29 2.74E-06 0.034 51.87
0.342 3.23E-06 0.04 61.13
0.411 3.88E-06 0.048 73.4
0.671 6.33E-06-' 0.078 119.96
initial
5
15
20
25
30
35
40
45
C3"
0D
0-
0
0-
CD
C$
Wa
13.82
6.01
31.49
36.6
33.96
17.24
957.
25.62
45.64
90.24
-L: -- __ _, a __ __ _ - 1
Cytochrome c Sufactant Experiment- Bioanalyzer Data
For a second method of comparison, both the organic and aqueous phases of the
cytochrome c surfactant experiment were analyzed by the Agilent Bioanalyzer 2100.
Figure 16 below shows an example of electrophoresis gels of the aqueous phases of one
run of one experiment. The leftmost gel, labeled L', is the ladder. Gels I through 10 are
aqueous samples I through 10 for a particular run. 'The lower marker is 4.5kDa and the
upper marker is 24OkDa. As in a normal gel, a line represents the approximate size of a
protein in the sample.
gadder Cyt 3urfacta... Cyt 3ufat... Cyt 5urfacta... Cyt Surfart... Cyt 5urfacta... Cut surfacta... Cyt Strfacta... Cyt 3urfota,.. Cyt Surfycta... Cyt Sarfacta...
240 f . ..... . .. e ... .. :240
63- -63
16 -
-76
is - X 1 .5
L 1 2 3 4 S 6 7 5 9 10
Figure 16. sample Gel Output of Aqueous phases for Cytochrome c surfactant Experiment using Agilent
Bioanalyzer 2100
Figure 17 below represents a sample electropherogram for the same samples in
the figure above. The x-axis is in kta and the y-axis is in FU (functional units). The
Agilent Bioanalyzer quantifies the electropherogram results by calculating the area under
the curve. A relative concentration (in ng/uL) and % total is found for each peak on the
electropherogram and corresponding line on the gel, representing a protein of a particular
size (kDa). Sample peak tables can be found in Table 14.
Foily 5 od 1100-Runs-Al [Fu) Coo Sw aoatRunt-AZ [FU) yt S ad ano-T c A3
400 301 300
300
2000oo200
2001010
300 300 3000
z00 200 2000
10001031000
4S 15 4 50150 X05 NM~I 45005 450150 240 [kl~aI 45105 4 55 1550240 0110111
Fu] Cyo Surfatan-an-A7 (FUGICyt Surfactant-Runt-A8 FIJjCy 0tnfaceaunlA5
300 300
2000020
100 00 100
00 - '0
4515 4501550245 IkdaI 49 15 4 1500 045 111a1 45 10456 150 2454 010a1
FUJ] Cyt udactana-RunI AW [FU[ Ladder
1000
0 0
4 45 C 05550 40 [SoDaJ -4 15 46 5 0 5000 240 Iloaa[
Figure 17. Sample Electropherogram of Aqueous phases for Cytochrome c Surfactant Experiment using
Agilent Bioanalyzer 2100
Table 14. Sample Peak Tables for Aqueous phases for Cytochrome c Surfactant Experiment using Agilent
l3ioanalyzer 2100
RelaivSample Peak Size (kDa) Concentration n Total Observations
R 4.5 0.00.0 SyserMPak
Run 1- Aqueous 3 6.3 0.0 0.0 SystemPeak
Sample 1 3 7.0 0.0 0.0 S tem Peak
4 15.4 33. 0.
5 u400 60.00.0S stMak
1 4.5 0.000LwrMre
2 50.0 0.0 System Peak
Run 1- AqueouS 3 6.3 0.0 0.0 SytemnPeak
Sample 2 4 7.0 0.7 04 P
5 2.7 24
60.0 0.0 U rMarker
0.0 0.0 Lower Marker
Run 1- Aqueous 3 64 0.0 0.0 Sstem Peak
Sample 3 3 7.1 0.0 0.05tem Peak
4 15.4 30.9100-
5 240.0 60.0 0.0 Upr Marker
1 .5 0.0 0.0 LowerMarker
2 6.4 0.0 0.0 5 mPeak
Run 1- Aqueous 3 7.2 0.0 0.0 Stem Peak
Sample 4 4 15.6 16.8 100
5 - 233.7 1.96-
5 240.0 60.0 0.0 Upr Marker
400 0.0 Lower Marker
2 5.8 0.0 0.0 S tem Peak
Run 1-Aqueous 3 6.4 0.0 0.0 Stem Peak
Sample 8 5 1.0 ___________
5 15.4 15910
2. 5.9 -
620060.0 0.0 Uppr Marker
450.0 0.0 Lower Marker
Ru .Auos 2 6.4 0.0 0.0 S$tm Peak
Run S-Aqueous 3 7.0 0.0 0.0 Stem Peak
Sample 6 4 15.4 19.3100
5 240.0 60.0 0.0 UrMarker
1 4.5 0.0 0.0 Lower Marker
Ru -Auos 2 6.4 0.0 0.0 Systemn Peak
RuSaquleous 3 .4 160.87.9 __________Peak
Sml10 4 22.7 27.8 12.7 -
5 2403.362.3000 __U_____rMarker_
3.1_______ 0.0 0.0 Uowr Marker
The information in Table 14 can be used to make an extraction profile to compare
to Figures 18 and 19. Figures 18 and 19 below show the extraction profiles for
cytochrome c varying surfactant concentration using Bioanalyzer results from the organic
and aqueous phases, respectively.ff Cytochrome c Surfactant Experiment- Organsic Pbas e, I~ioanalyzer 1
0
0 "
160-
140 -
120-
100 -
80 
-
40
20
0
0 5 6010 20 30
AOT (mM)
Figure 18. Previous Cytocharomle c Extraction Yield vs. AOT concentration
(aqueous: IlgL cyt c, 0I.02M Tris buffer, pH-9.7, organic: 5 to 50mM AOT in isooctane)
Cytochronie e S urfactant Experlient- Aqueous phase,
Bionnalyzer Data
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Figure 19. Previous Cytochrome c Extraction Yield vs. AOT concentration
(aqueous: I g/L cyt c, 0.02M Tris buffer, pH-9.7, organic: 5 to 50mM AOT in isooctane)
ytocnrome c vasymg strrrac~ant concenr;rnd aqueous ph es, resp ctively.Cytochrome c SurPa tant ~up160-1 - ----- - -- -
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As with the data analyzed by spectropolarimeter, the organic and aqueous phases
analyzed by the Agilent Bioanalyzer do not sum to 100%. Also, Figure 18 does not
compare to Figure 14, and Figure 19 does not compare to Figure 15. Therefore, this
second method of analysis was not used for the Results section of this thesis.
APPENDIX D
DsRed2 Purification
Examples of anion exchange chromatography graphs for DsRed2 are below.
Fractions were collected of the single DsRed2 peak monitored at 561 mn
Sample AX I
800
700
S600
i 500
-- UV 280
r Yrr400-
a 300 Gradient
-
10
0 50 100 150
Volume (mLt)
Figure 20. Example of Anion Exchange Chromatography Graph for Dsked2 (Gradient of 6 column
volumes)
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Sample AX 2
400
350
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- U 8
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0V28
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Figure 21. Example of Anion Exchange Chromatography Graph for DsRed2 (Gradient of 6 column
volumes)
Sample AX 3
2000
1800
~1600
1400
~1200 
--- UV 280
S1000
----------------UV561
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S600
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~2000 
1 .0 
50 100 150
Volume (miL)
Figure 22. Example of Anion Exchange Chromatography Graph for DsRed2 (Gradient of 6 column
volumes)
The purification of DsRed2 after anion exchange chromatography and
ultrafiltration was confirmed using the Agilent Bioanalyzer 2 100. Examples of the
Bioanalyzer output are below.
DsRed2 After AX Before Ultrafilfration
FU I] ORed2+DTT, before ift...
80a
700
600
500
4000
300
200
100J
Figure 23. Example of Electropherogramn of D 150trano xcag chromatography but before
Table 15. Sample Peak Tables of DsRed2 after anion exchange chromatography, but before ultrafiltration
Size (kDa3
4.5
5.7
6.4
7.2
13.8
17.0
19.3
22.0
27.4
41.3
43.3
49.5
57.6
70.0
74.8
83.5
96.8
106.0
115.3
139.5
155.7
171.3
215.0
228.8
240.0
59.
36.
19.
160 0.4
29. .7
274. ,1.
2054 2.7
196 0.1
189 0.1
31.0 0
175 0.1
239 0.1
457 0.2
913 0.3
121 0.7
448 0.2
166 0.1
802 0.2
600 0.0 UprMre
,Observations
0.0 0.0 Lower Marker
0.0 0.0 System Peak
0.0 0.0 System Peak
0.0 0.0 System Peak
UperMake
1504.5 7 15 28 46 63 95 240
Figure 24. Example of Electropherogram of DsRed2 after anion exchange chromatography and
ultrafiltration (5OkDa membrane)
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DsRed2 After AX and UltraFiltration
[Fug
1000-
500-
0-
83.5 ~7,517 9f~.8 23.9~s 106.0 45,7g ~~S 3 91 3to J9 X 2.~21 55~7 4 82 r'7 , 373 2 10 16.628 8 80 25 40.Q 6(1 0
1 ~3 ~/h
1 13 r ~1 u ~l~ V
Table 16. Sample Peak Tables of DsRed2 after anion exchange chromatography and ultrafiltration (50kDa
membrane)
Size [kDal Rel. Conc. [ng/fjlj % Total Observations
1 4.5 0.0 0.0 Lower Marker
2 5.6 0.0 0.0 System Peak
3 7.0 0.0 0.0 System Peak
4 16.5 72.8 3.3
5 20.1 255.2 11.4
6 25.1 26.9 1.2
7 27.4 1,724.1 77.2
8 37.0 90.9 4.1
9 53.7 44.4 2.0
10 65.6 18.2 0.8
11 232.6 1.1 0.0
12 240.0 60.0 0.0 Upper Marker
